Randomized phase III trial of paclitaxel/carboplatin with or without PF-3512676 (Toll-like receptor 9 agonist) as first-line treatment for advanced non-small-cell lung cancer

Research output: Contribution to journalArticlepeer-review

Standard

Randomized phase III trial of paclitaxel/carboplatin with or without PF-3512676 (Toll-like receptor 9 agonist) as first-line treatment for advanced non-small-cell lung cancer. / Hirsh, Vera; Paz-Ares, Luis; Boyer, Michael; Rosell, Rafael; Middleton, Gary; Eberhardt, Wilfried E E; Szczesna, Aleksandra; Reiterer, Pavel; Saleh, Mansoor; Arrieta, Oscar; Bajetta, Emilio; Webb, Roy T; Raats, Johannes; Benner, Rebecca J; Fowst, Camilla; Meech, Sandra J; Readett, David; Schiller, Joan H.

In: Journal of Clinical Oncology , Vol. 29, No. 19, 2011, p. 2667-74.

Research output: Contribution to journalArticlepeer-review

Harvard

Hirsh, V, Paz-Ares, L, Boyer, M, Rosell, R, Middleton, G, Eberhardt, WEE, Szczesna, A, Reiterer, P, Saleh, M, Arrieta, O, Bajetta, E, Webb, RT, Raats, J, Benner, RJ, Fowst, C, Meech, SJ, Readett, D & Schiller, JH 2011, 'Randomized phase III trial of paclitaxel/carboplatin with or without PF-3512676 (Toll-like receptor 9 agonist) as first-line treatment for advanced non-small-cell lung cancer', Journal of Clinical Oncology , vol. 29, no. 19, pp. 2667-74. https://doi.org/10.1200/JCO.2010.32.8971

APA

Hirsh, V., Paz-Ares, L., Boyer, M., Rosell, R., Middleton, G., Eberhardt, W. E. E., Szczesna, A., Reiterer, P., Saleh, M., Arrieta, O., Bajetta, E., Webb, R. T., Raats, J., Benner, R. J., Fowst, C., Meech, S. J., Readett, D., & Schiller, J. H. (2011). Randomized phase III trial of paclitaxel/carboplatin with or without PF-3512676 (Toll-like receptor 9 agonist) as first-line treatment for advanced non-small-cell lung cancer. Journal of Clinical Oncology , 29(19), 2667-74. https://doi.org/10.1200/JCO.2010.32.8971

Vancouver

Author

Hirsh, Vera ; Paz-Ares, Luis ; Boyer, Michael ; Rosell, Rafael ; Middleton, Gary ; Eberhardt, Wilfried E E ; Szczesna, Aleksandra ; Reiterer, Pavel ; Saleh, Mansoor ; Arrieta, Oscar ; Bajetta, Emilio ; Webb, Roy T ; Raats, Johannes ; Benner, Rebecca J ; Fowst, Camilla ; Meech, Sandra J ; Readett, David ; Schiller, Joan H. / Randomized phase III trial of paclitaxel/carboplatin with or without PF-3512676 (Toll-like receptor 9 agonist) as first-line treatment for advanced non-small-cell lung cancer. In: Journal of Clinical Oncology . 2011 ; Vol. 29, No. 19. pp. 2667-74.

Bibtex

@article{8edecade4897453b86ea0ef86fe5ba79,
title = "Randomized phase III trial of paclitaxel/carboplatin with or without PF-3512676 (Toll-like receptor 9 agonist) as first-line treatment for advanced non-small-cell lung cancer",
abstract = "This phase III study examined efficacy of the synthetic Toll-like receptor 9-activating oligodeoxynucleotide PF-3512676 in combination with standard paclitaxel/carboplatin chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC).",
author = "Vera Hirsh and Luis Paz-Ares and Michael Boyer and Rafael Rosell and Gary Middleton and Eberhardt, {Wilfried E E} and Aleksandra Szczesna and Pavel Reiterer and Mansoor Saleh and Oscar Arrieta and Emilio Bajetta and Webb, {Roy T} and Johannes Raats and Benner, {Rebecca J} and Camilla Fowst and Meech, {Sandra J} and David Readett and Schiller, {Joan H}",
year = "2011",
doi = "10.1200/JCO.2010.32.8971",
language = "English",
volume = "29",
pages = "2667--74",
journal = "Journal of Clinical Oncology ",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "19",

}

RIS

TY - JOUR

T1 - Randomized phase III trial of paclitaxel/carboplatin with or without PF-3512676 (Toll-like receptor 9 agonist) as first-line treatment for advanced non-small-cell lung cancer

AU - Hirsh, Vera

AU - Paz-Ares, Luis

AU - Boyer, Michael

AU - Rosell, Rafael

AU - Middleton, Gary

AU - Eberhardt, Wilfried E E

AU - Szczesna, Aleksandra

AU - Reiterer, Pavel

AU - Saleh, Mansoor

AU - Arrieta, Oscar

AU - Bajetta, Emilio

AU - Webb, Roy T

AU - Raats, Johannes

AU - Benner, Rebecca J

AU - Fowst, Camilla

AU - Meech, Sandra J

AU - Readett, David

AU - Schiller, Joan H

PY - 2011

Y1 - 2011

N2 - This phase III study examined efficacy of the synthetic Toll-like receptor 9-activating oligodeoxynucleotide PF-3512676 in combination with standard paclitaxel/carboplatin chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC).

AB - This phase III study examined efficacy of the synthetic Toll-like receptor 9-activating oligodeoxynucleotide PF-3512676 in combination with standard paclitaxel/carboplatin chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC).

U2 - 10.1200/JCO.2010.32.8971

DO - 10.1200/JCO.2010.32.8971

M3 - Article

C2 - 21632509

VL - 29

SP - 2667

EP - 2674

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 19

ER -